CHIP has been implicated in cardiovascular diseases [18, 23–35] and metabolic disorders [67] and is increasingly suspected to play a role in neurodegenerative conditions [68], highlighting its broader influence on aging and the progression of chronic diseases. Here, STUB1 is linked to metabolic disease.